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http://dx.doi.org/10.1016/j.jmii.2014
1684-1182/Copyright ª 2014, TaiwanWe report a drug reaction with eosinophilia and systemic symptoms case of primary Epsteine
Barr virus (EBV) infection, in which the diagnosis was first confirmed by lymphocyte transfor-
mation tests (LTT). LTTs were positive for cefditorenepivoxil and acetaminophen. LTT, EBV
load, and anti-EBV antibodies could allow early diagnosis of drug reaction with eosinophilia
and systemic symptoms, which masquerades with the clinical features of infectious mononu-
cleosis.
Copyrightª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Drug allergy occasionally causes a severe, multiorgan sys-
temic reaction. Drug reaction with eosinophilia and sys-
temic symptoms (DRESS)/drug-induced hypersensitivitynt of Pediatrics, Graduate
University, 3-1-1 Maidashi,
iatr.med.kyushu-u.ac.jp
.06.012
Society of Microbiology. Publishedsyndrome (DIHS) is a severe drug hypersensitivity reaction
that is characterized by fever, skin eruption, cervical
lymphadenopathy, leukocytosis with atypical lymphocytosis
and/or eosinophilia, and liver dysfunction.1 Causative drugs
range widely and include anticonvulsants and antimicrobial
agents. DRESS is often associated with the reactivation of
the herpes virus family represented by human herpes virus
(HHV)-6, EpsteineBarr virus (EBV), and cytomegalovirus.1
By contrast, DRESS has rarely been reported in patients
during acute primary infection of the viruses. The diagnosis
of high-risk drug eruption is challenging because the
sensitivity tests would give false negative results in patientsby Elsevier Taiwan LLC. All rights reserved.
110 E. Nanishi et al.with StevenseJohnson syndrome, toxic epidermal necrol-
ysis, and DRESS/DIHS.2
We report herein a case of DRESS, which developed
during the course of primary EBV infection. The early
diagnosis of DRESS was first made by the positive lympho-
cyte transformation test (LTT) for acetaminophen and
cefditorenepivoxil (CDTR-PI).
Case report
A previously healthy 4-year-old boy was admitted to our
hospital on the 14th day of illness because of prolonged
fever, jaundice, and generalized skin eruption. The patient
had received oral CDTR-PI and acetaminophen suppository
from the 6th day to the 12th day of illness. Despite the
defervescence on the 11th day of illness, jaundice and
abdominal pain emerged. On the 13th day of illness, he
presented to a practitioner again because of developing
generalized skin rash. The laboratory findings showed
increased levels of: aspartate aminotransferase, 1821 U/L;
alanine aminotransferase, 1777 U/L; total bilirubin,
6.8 mg/dL; and direct bilirubin, 5.1 mg/dL. He was then
referred to us for further management.
On admission, his body temperature was 38.0C. Skin
and bulbar conjunctiva were icteric. Pruritic mac-
ulopapular eruption spread confluently on the trunk, ex-
tremities, palms, and soles (Fig. 1). Mucous membranes and
conjunctivas were spared. There was cervical lymphade-
nopathy, hepatomegaly, but no splenomegaly. Complete
blood counts showed a leukocyte count of 3.99  109/L
with 26% segmented neutrophils, 55% lymphocytes, 10%
monocytes, 4% eosinophils, and 5% atypical lymphocytes, a
hemoglobin concentration of 11.7 g/dL and a platelet
count of 143  109/L. Blood chemistry showed: total bili-
rubin, 7.8 mg/dL; direct bilirubin, 5.6 mg/dL; aspartate
aminotransferase, 570 U/L; alanine aminotransferase,
894 U/L; lactate dehydrogenase, 637 U/L; and g-glutamylFigure 1. Maculo-papular eruption confluently spreading over (A
The photographs were taken at the time of admission.transpeptidase, 348 U/L. C-reactive protein concentration
was 0.09 mg/dL. Serum levels of ferritin (1492 mg/dL) and
soluble interleukin-2 receptor (6061 U/mL) were both high.
Immunoglobulin levels and coagulation studies were unre-
markable (immunoglobulin E < 10 U/mL). Surface maker
analysis of the peripheral blood lymphocytes showed a
reversed CD4/CD8 ratio (0.45) and a prominently increased
proportion of activated CD8þT cells (72.2%). There were
past inactive infections, but no reactivations of cytomeg-
alovirus or HHV-6. Positive antiviral capsid antigen immu-
noglobulin M with negative anti-EBV nuclear antigen
antibody indicated primary EBV infection. A high copy
number of EBV-DNA (3  106 copies/L of peripheral blood)
was detected by real-time polymerase chain reaction. LTT
for acetaminophen [stimulation index (SI) 555%] or CDTR-PI
(SI 314%) was highly positive. The diagnosis of DRESS was
made because the patient fulfilled all but one criteria of
eosinophilia. Dexchlorpheniramine and glycyrrhizinate
were started with no use of the other drugs including an-
tipyretics. All symptoms resolved until the cessation of
therapy on the 19th day of illness. Negative LTT for acet-
aminophen (SI 81%) or CDTR-PI (SI 71%) was confirmed 2
months later. Thereafter, skin eruption did not appear
when acetaminophen was administered at the chance of
fever.
Discussion
Drug reactions in childhood are often challenging to di-
agnose because of accompanying viral diseases presenting
cutaneous manifestation. The diagnostic criteria of DRESS/
DIHS overlap the representative manifestations of infec-
tious mononucleosis (IM). DRESS was first confirmed by the
positive LTT in this pediatric patient with primary EBV
infection. This observation suggests an unexpected utility
of LTT for the correct diagnosis of DRESS associated with
primary EBV infection.) the whole body and (B) extremities involving palms and soles.
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DRESS associated with primary EBV infection 111Reactivation of herpes virus infection concurrent with
drug hypersensitivity is considered specific to DRESS. Only
three patients have been previously reported to develop
DRESS during primary EBV infection.3e5 As shown in Table 1,
there was no LLT recorded. These patients had prolonged
fever, skin rash, and atypical lymphocytosis, but not always
other typical expressions of acute IM. The present patient
showed slight neutropenia and thrombocytopenia, but no
eosinophilia. High serum levels of soluble interleukin-2 re-
ceptor and ferritin during the acute phase indicated the
excessive immune activation leading to hemophagocytic
syndrome, when eosinophilia is unusual. Pituitary adrenal
axis might result in the modest increase of eosinophil
counts during the convalescent phase (18th day of illness:
0.29  109/L).6 Severe immune responses to the virus
reactivation may explain the clinical manifestations of
DRESS. Picard et al1 found that the reactivation of HHV-6,
HHV-7, and EBV and the proliferation of activated CD8þT
cells, which recognize EBV epitopes in most patients. The
culprit drugs triggered the virus replication in EBV-
transformed B cells from the patients. Picard et al1 indi-
cated that cutaneous and visceral symptoms of DRESS are
mediated by activated CD8þT cells largely directed against
herpes viruses such as EBV. Therefore, primary EBV-
infected patients might be at risk of developing drug re-
action augmented by the activated CD8þT cells. Both LTT
for acetaminophen and CDTR-PI were definitely positive in
the present patient. These drugs are chemically different
and are metabolized through different pathways. Multidrug
hypersensitivity rather than the cross reaction may explain
the distinct manifestation although no skin patch test was
performed.
Ampicillin (or amoxicillin) administration precipitates
exanthema in >95% of adults, but is less common in chil-
dren, with EBV-associated IM. Exanthema develops in
3e15% of IM patients not treated with b-lactam antibiotics.
“Ampicillin rash” is explained by the mechanism of the
proliferation of EBV-reactive CD8þ T cells enhances the
sensitivity to the drug. Renn et al7 reported that the drug
eruption occurs as the aminopenicillin-specific reaction.
However, commonly used b-lactam antibiotics (cefotax-
ime), along with ampicillin, could be culprit drugs of
DRESS.8 With this background, exanthema in IM patients
should be cogently differentiated from the prodrome of
DRESS.
In the present patient, the positive result of LTT came to
be negative with the favorable clinical course. Kano et al2
reported that positive LLT was obtained at an acute phase
of toxic epidermal necrolysis or StevenseJohnson syn-
drome, but was later observed 5e8 weeks after the onset of
DRESS. The proportion of circulating T cell subsets from
patients affects the in vitro result of LTT. Functional reg-
ulatory T cells at the acute stage of DRESS may serve to
prevent the activation and expansion of drug-specific T
cells.9 However, the proportion of regulatory T cells was
reported to decrease in patients with primary infection, but
not with reactivation of EBV.10 Further study is needed to
determine the sensitivity of LLT during the acute and
convalescent phase of primary EBV infection assessed by
the analysis of functional T cell subpopulations. Sequential
LLT may be useful to determine the ominous hypersensi-
tivity to drugs in patients with the primary infection of EBV.
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